ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC) Options
Participant consumed grapefruit or grapefruit products and solutions within three days before the primary dose of study drug.- "Our study unveiled the important purpose of your KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, which include OTX015 or ABB